Refinitiv Perspectives

Enhanced Due Diligence

COVID-19 and healthcare due diligence

Apr 2, 2020 • Phil C.

Most Read

Thanks for subscribing

You’ve signed up to our weekly newsletter to get the latest Industry insights. You can unsubscribe at any time.

Find us here

Generating Insights From Data

Building an alternative data ecosystem

Apr 2, 2020 • John W. • Bob B.

Popular

ESG Data

Lowering barriers to sustainable investing

Mar 27, 2020 • Elena P.

Popular

Third-Party Risk

Cutting the risks on Hong Kong IPOs

Apr 3, 2020 • Henry F.

Trending

#SmarterTrading

Refinitiv’s University Dealing Challenge

Mar 27, 2020 • Daryl S.

Deal Insights

COVID-19 bursts M&A activity optimism

Mar 26, 2020 • Matthew T.

@refinitiv on Twitter

#SmarterTrading

COVID-19: A test of FX trading continuity

Mar 24, 2020 • Refinitiv

#SmarterTrading

Finding fair value amid oil price volatility

Mar 24, 2020 • Abdellah A.

FinTech

Digital Finance and Crisis

Mar 23, 2020 • Julia W.

Managing & Integrating Data

Meeting the market’s evolving needs

Mar 20, 2020 • Matt E.

AI & Machine Learning

Next-level NLP and potential ESG controversies

Mar 20, 2020 • Jo S.

Third-Party Risk

COVID-19: Lessons from supply chain disruption

Mar 17, 2020 • Nicholas B.

Trading Insights

Relive The Six Nations 2020 on the Global Sports Forum

COVID-19

Coronavirus ‘infodemic’: A data-driven approach to countering irrational market emotions

Mar 16, 2020 • Richard G.

Awards & Events

Excellence in the Austria Fund Industry

Popular topics: